Serum miR-22 as Potential Non-Invasive Predictor of Poor Clinical Outcome in Newly Diagnosed, Uniformly Treated Patients With Diffuse Large B-Cell Lymphoma: An Explorative Pilot Study
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0768-5
Full Text
Open PDFAbstract
Available in full text
Date
May 2, 2018
Authors
Publisher
Springer Science and Business Media LLC